A federal audit of the Belgian radiotherapy departments in breast cancer treatment>

Radiotherapy and Oncology

Volumn 83, Issue 2, 2007, Pages 178-186

  Van Houtte, Paul ^a   Bourgois, Nicolas ^a   Renard, Françoise ^b   Huget, Philippe ^a   D'hoore, William ^c   Scalliet, Pierre ^d  

^a Department of Radiation Oncology ^*  (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Breast cancer; Quality audit; Radiotherapy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CONSERVATIVE TREATMENT; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; GOVERNMENT; HEALTH CENTER; HEALTH PRACTITIONER; HOSPITAL DEPARTMENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL INFORMATION; MICROSCOPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; VOLUNTARY PROGRAM;

ADULT; AGED; AGED, 80 AND OVER; BELGIUM; BREAST NEOPLASMS; FEMALE; HUMANS; MEDICAL AUDIT; MIDDLE AGED; RADIATION ONCOLOGY; RADIOTHERAPY DOSAGE; WAITING LISTS;

EID: 34249085091     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.03.011     Document Type: Article

References (34)

1. Van der Schueren E., Horiot J.C., Leunens G., et al. Quality assurance in cancer treatment. Report of a Working Party from the European School of Oncology. Eur J Cancer 29 (1993) 172-181
2. Bartelink H., Horiot J.C., and Poortmans P. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345 (2001) 1378-1387
3. Mauriac L. Standards, options and recommendations for non-metastatic breast cancer patients. Bull Cancer 89 (2002) 207-224
4. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 2000;355:1757-70.
5. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337 (1997) 956-962
6. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
7. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 53 (1993) 1641-1648
8. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 (2005) 116-126
9. Whelan T.J., Julian J., Wright J., et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 8 (2001) 1220-1229
10. Clarkes M., Collins R., and Darby S. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
11. Ferreira I.H., Dutreix A., Bridier A., et al. The ESTRO-QUAlity assurance network (EQUAL). Radiother Oncol 55 (2000) 273-284
12. Izewska J., and Andreo P. the IAEA/WHO TLD postal programme for radiotherapy hospitals. Radiother Oncol 54 (2000) 65-72
13. Thwaites D., Scalliet P., Leer J.W., et al. Quality assurance in radiotherapy: European society for therapeutic radiology and oncology advisory report to the commission of the European union for the 'Europe Against Cancer Programme'. Radiother Oncol 35 (1995) 61-73
14. Esik O., Seitz W., Lövey J., et al. External audit on the clinical practice and medical decision-making at the departments of radiotherapy in Budapest and Vienna. Radiother Oncol 51 (1999) 87-94
15. Jaarvinen H., Wigren T., Berg P., et al. Three steps to clinical audit in radiotherapy. Radiother Oncol 76 (2005) S80-S81
16. Mayer R., Handl-Zeller L., Quehenberger F., et al. Patterns of care in radiotherapy of breast cancer in Austria 1985: data acquisition and comparison with data of US-PCS 1983. Radiother Oncol 72 (2004) 45-51
17. Solin L.J., Fowble B.L., Martz K.L., et al. Results of the 1983 patterns of care process survey for definitive breast irradiation. Int J Radiat Oncol Biol Phys 20 (1991) 105-111
18. Mitsumori M., Hiraoka M., Negoro Y., et al. The patterns of care study of breast-conserving therapy in Japan: analysis of process survey from 1995-1997. Int J Radiat Oncol Biol Phys 62 (2005) 1048-1054
19. Koshy A., Buckingham J.M., Zhang Y., et al. Surgical management of invasive breast cancer: a 5-year prospective study of treatment in the Australian Capital Territory and South-Eastern New South Wales ANZ. J Surg 75 (2005) 757-761
20. Birkmeyer J.D., Stukel T.A., Siewers A.E., et al. Surgeon volume and operative mortality in the United Staes. N Engl J Med 349 (2003) 2117-2127
21. Voordeckers M., Van de Steene J., Vinh-Hung V., et al. Adjuvant radiotherapy after mastectomy for pT1-pT2 node negative (pN0) breast cancer: is it worth the effort?. Radiother Oncol 68 (2003) 227-231
22. Pierce L.J., Moughan J., White J., et al. 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer. Int J Radiat Oncol Biol Phys 62 (2005) 183-192
23. Ceilley E., Jagsi R., Goldberg S., et al. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey. Int J Radiat Oncol Biol Phys 61 (2005) 365-373
24. Taghian A.G., Jeong J.H., Mamounas E.P., et al. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from 5 national surgical adjuvant breast and bowel project randomized clinical trials. J Clin Oncol 24 (2006) 3927-3932
25. Poortmans P., Kouloulias V.E., Venselaar J.L., et al. Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary - medial supraclavicular irradiation in stage I-III breast cancer: the individual case review. Eur J Cancer 39 (2003) 2035-2042
26. Taghian A., Jagsi R., Makris A., et al. Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: practice is culture driven rather than evidence based. Int J Radiat Oncol Biol Phys 60 (2004) 706-714
27. Valdagni R., Amichetti M., and Ciocca M. Patterns of radiotherapy for early breast cancer in Northern Italy compared with European and national standards. Radiother Oncol 51 (1999) 79-85
28. Drummond R., Power A., Evans A., et al. Changes in practice of breast cancer radiotherapy 1998-2002: an Australian survey. Australas Radiol 49 (2005) 44-52
29. Improving outcomes in breast cancer. National Institute for Clinical Excellence, London; 2002.
30. Robinson D., Massey T., David E., et al. Waiting times for radiotherapy: variation over time and between cancer networks in southeast England. B J Cancer 92 (2005) 1201-1208
31. Guidance on the development and management of devolved radiotherapy service. Royal College of Radiologists, London; 2004.
32. Richards M.A., Westcombe A.M., Love S.B., et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353 (1999) 1119-1126
33. Huang J., Barbera L., Brouwers M., et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 21 (2003) 555-563
34. Recueil des bonnes pratiques organisationnelles en radiothérapie. MeaH (Mission Nationale d'Expertise et d'Audit Hospitaliers), Paris; 2004.